|Bid||25.30 x 1100|
|Ask||199,999.98 x 900|
|Day's Range||25.74 - 27.01|
|52 Week Range||24.11 - 27.76|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||35.00|
NEW YORK, Aug. 14, 2018-- Establishment Labs Holdings Inc., a medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction ...
Establishment Labs (ESTA) today announced that the Company will release its second quarter 2018 financial results on Tuesday, August 14, 2018, prior to the open of U.S. financial markets. Establishment Labs will host a conference call and webcast at 9:00 a.m. Eastern Time on Tuesday, August 14, 2018 to discuss its financial results. The dial-in number to access the call is U.S./Canada (877) 376-9925, International (629) 228-0732, and the conference ID is 1768049.
Public-market investors’ embrace of health-care startups is extending beyond biotechnology to medical-technology companies. Twenty-nine venture-backed health-care startups went public in the first half, equaling the 2017 yearly total, according to market tracker Dow Jones VentureSource. Biotech had 26 IPOs in the first half of 2018 and 25 in all of 2017, according to VentureSource.
Establishment Labs Holdings Inc. (ESTA), a global medical technology company focused on breast aesthetics and reconstruction technologies, today announced the closing of its initial public offering of 4,272,568 common shares, including the full exercise by the underwriters of their option to purchase 557,291 additional common shares, at a public offering price of $18.00 per share. All of the common shares were offered by Establishment Labs. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses payable by Establishment Labs, were approximately $76.9 million.
NEW YORK, July 19, 2018-- Establishment Labs Holdings Inc. today announced that the company’ s common stock commenced trading on the Nasdaq Stock Market under the trading symbol“ ESTA” following its initial ...
Health-care startups kept up this year’s brisk pace of initial public offerings Thursday, with Establishment Labs Holdings Inc., Constellation Pharmaceuticals Inc. and Allakos Inc. making their market ...
Establishment Labs Holdings Inc. (ESTA), a global medical technology company focused on breast aesthetics and reconstruction technologies, today announced the pricing of its initial public offering of 3,715,277 common shares at a public offering price of $18.00 per share. All of the common shares are being offered by Establishment Labs. In addition, Establishment Labs has granted the underwriters a 30-day option to purchase up to 557,291 additional common shares at the initial public offering price, less underwriting discounts and commissions.